Sponsor study identifier
observational
200
1 country
1
Study Start
June 15, 2024
Actual (reported)Primary Completion
December 30, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
December 30, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
The purpose of this study is to characterize organ dysfunction change in acute necrotizing pancreatitis patients with sepsis after open necrosectomy.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
December 30, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 26, 2024
Actual (reported)April 24, 2024
Actual (reported)June 15, 2024
Actual (reported)December 30, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
December 30, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Measure organ dysfunction change after open necrosectomy with respect to time
Organ dysfunction will be measured using sequential organ failure assessment score scale. The scores range from 0 (normal) to 4(most abnormal) for each organ, with higher scores indicating worse health status
up to postoperative day 7, or at hospital discharge, whichever comes first
incidence of a composite of major complications
up to postoperative day 28
Incidence of ICU mortality
through study completion, an average of 1year
Incidence of hospital mortality
through study completion, an average of 1 year
Incidence of 28-day mortality
through study completion, an average of 1 year
Incidence of one year mortality
through study completion, an average of 1 year
Acute necrotizing pancreatitis patients with sepsis undergoing open necrosectomy will be measured SOFA scores at a special time point to characterize organ dysfunction experience profiles.
Study the dynamic nature of organ dysfunction
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Acute necrotizing pancreatitis Patients with sepsis scheduled for open necrosectomy will be invited to participate in this study.
West China Hospital, Sichuan University
Chengdu, China, 610041, China
Fengming Luo, PhD
West China Hospital
First Submitted
March 26, 2024
First Posted
April 24, 2024
Study Start
June 15, 2024
Actual (reported)Primary Completion
December 30, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Timing of Transmural Stent Removal in Necrotizing Pancreatitis
Contact the study team to confirm eligibility.
Study Completion
December 30, 2026
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
July 10, 2026
Record last verified: 2025-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: